Pharmacy

ADCEF GENERIC Cefdinir

Home » Prescription Drugs 1 » ADCEF GENERIC Cefdinir

Cefdinir is an antibiotic used to treat certain infections caused by bacteria such as pneumonia bronchitis ear infections sinusitis pharyngitis tonsillitis and skin infections. Antibiotics will not work for colds flu or other viral infections.Cefdinir comes as a capsule and as an oral suspension. It is usually taken once or twice a day. Shake the suspension well before each use to mix the medication evenly. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take cefdinir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Continue to take cefdinir even if you feel well. Do not stop taking cefdinir without talking to your doctor.

Buy ADCEF GENERIC Cefdinir and other Prescription Drugs 1 products online at Medstore.

Buy Online at Medstore - Click Here!

About ADCEF GENERIC Cefdinir:

Product Type: Prescription Drugs 1

ADCEF ( GENERIC Cefdinir )

ADCEF (GENERIC Cefdinir)

GENERIC Cefdinir

300MG 100 (2 x 50) Tablets 50 Tablets GENERIC Cefdinir ADCEF

View more Prescription Drugs 1

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.